These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 25644835)

  • 21. Direct ChIP-bisulfite sequencing reveals a role of H3K27me3 mediating aberrant hypermethylation of promoter CpG islands in cancer cells.
    Gao F; Ji G; Gao Z; Han X; Ye M; Yuan Z; Luo H; Huang X; Natarajan K; Wang J; Yang H; Zhang X
    Genomics; 2014; 103(2-3):204-10. PubMed ID: 24407023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypermethylation of a New Distal Sodium/Iodide Symporter (NIS) enhancer (NDE) is associated with reduced NIS expression in thyroid tumors.
    Galrão AL; Camargo RY; Friguglietti CU; Moraes L; Cerutti JM; Serrano-Nascimento C; Suzuki MF; Medeiros-Neto G; Rubio IG
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E944-52. PubMed ID: 24432988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5.
    Seo EH; Kim HJ; Kim JH; Lim B; Park JL; Kim SY; Lee SI; Jeong HY; Song KS; Kim YS
    Int J Cancer; 2020 Jun; 146(12):3354-3368. PubMed ID: 32129880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Epigenetic Mechanism of High Gdnf Transcription in Glioma Cells Revealed by Specific Sequence Methylation.
    Zhang BL; Liu J; Lei Y; Xiong Y; Li H; Lin X; Yao RQ; Gao DS
    Mol Neurobiol; 2016 Sep; 53(7):4352-62. PubMed ID: 26232065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation.
    Baubec T; Colombo DF; Wirbelauer C; Schmidt J; Burger L; Krebs AR; Akalin A; Schübeler D
    Nature; 2015 Apr; 520(7546):243-7. PubMed ID: 25607372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
    Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
    BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orphan CpG islands define a novel class of highly active enhancers.
    Bell JSK; Vertino PM
    Epigenetics; 2017 Jun; 12(6):449-464. PubMed ID: 28448736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights from multidimensional analyses of the pan-cancer DNA methylome heterogeneity and the uncanonical CpG-gene associations.
    Liu Y; Huang R; Liu Y; Song W; Wang Y; Yang Y; Dong S; Yang X
    Int J Cancer; 2018 Dec; 143(11):2814-2827. PubMed ID: 30121964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
    Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
    Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
    [No Abstract]   [Full Text] [Related]  

  • 30. Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.
    Hu CY; Mohtat D; Yu Y; Ko YA; Shenoy N; Bhattacharya S; Izquierdo MC; Park AS; Giricz O; Vallumsetla N; Gundabolu K; Ware K; Bhagat TD; Suzuki M; Pullman J; Liu XS; Greally JM; Susztak K; Verma A
    Clin Cancer Res; 2014 Aug; 20(16):4349-60. PubMed ID: 24916699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and disease.
    Jeziorska DM; Murray RJS; De Gobbi M; Gaentzsch R; Garrick D; Ayyub H; Chen T; Li E; Telenius J; Lynch M; Graham B; Smith AJH; Lund JN; Hughes JR; Higgs DR; Tufarelli C
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):E7526-E7535. PubMed ID: 28827334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of genome-wide analysis techniques to DNA methylation analysis in human cancer.
    Soozangar N; Sadeghi MR; Jeddi F; Somi MH; Shirmohamadi M; Samadi N
    J Cell Physiol; 2018 May; 233(5):3968-3981. PubMed ID: 28888056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide DNA methylation analysis in precursor B-cells.
    Almamun M; Levinson BT; Gater ST; Schnabel RD; Arthur GL; Davis JW; Taylor KH
    Epigenetics; 2014 Dec; 9(12):1588-95. PubMed ID: 25484143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining Regulatory Elements in the Human Genome Using Nucleosome Occupancy and Methylome Sequencing (NOMe-Seq).
    Rhie SK; Schreiner S; Farnham PJ
    Methods Mol Biol; 2018; 1766():209-229. PubMed ID: 29605855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation of intronic enhancers directs tissue-specific expression of steroidogenic factor 1/adrenal 4 binding protein (SF-1/Ad4BP).
    Hoivik EA; Bjanesoy TE; Mai O; Okamoto S; Minokoshi Y; Shima Y; Morohashi K; Boehm U; Bakke M
    Endocrinology; 2011 May; 152(5):2100-12. PubMed ID: 21343250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole genome bisulfite sequencing of Down syndrome brain reveals regional DNA hypermethylation and novel disorder insights.
    Laufer BI; Hwang H; Vogel Ciernia A; Mordaunt CE; LaSalle JM
    Epigenetics; 2019 Jul; 14(7):672-684. PubMed ID: 31010359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia.
    Yamazaki J; Jelinek J; Lu Y; Cesaroni M; Madzo J; Neumann F; He R; Taby R; Vasanthakumar A; Macrae T; Ostler KR; Kantarjian HM; Liang S; Estecio MR; Godley LA; Issa JP
    Cancer Res; 2015 Jul; 75(14):2833-43. PubMed ID: 25972343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
    Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
    Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation patterns expose variations in enhancer-chromatin modifications during embryonic stem cell differentiation.
    Alajem A; Roth H; Ratgauzer S; Bavli D; Motzik A; Lahav S; Peled I; Ram O
    PLoS Genet; 2021 Apr; 17(4):e1009498. PubMed ID: 33844685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.
    Zhao J; Liang Q; Cheung KF; Kang W; Lung RW; Tong JH; To KF; Sung JJ; Yu J
    Cancer; 2013 Jan; 119(2):304-12. PubMed ID: 22833454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.